O’Reilly Automotive (NASDAQ:ORLY – Free Report) had its price objective upped by Guggenheim from $1,275.00 to $1,400.00 in a research note issued to investors on Friday,Benzinga reports. Guggenheim ...

In a report released today, David Arcaro from Morgan Stanley maintained a Hold rating on Centerpoint Energy (CNP – Research Report), with a ...

Endeavor Group holdings Inc (EDR) stock saw a modest uptick, ending the day at $31.61 which represents a slight increase of $0.71 or 2.30% from the prior close of $30.9. The stock opened at $30.93 and ...

Weight-loss drug developer Metsera is targeting an up to $1.78 billion valuation in its initial public offering, the ARCH Venture Partners-backed biotech company said on Monday. New York City-based ...

Johnson & Johnson (NYSE:JNJ – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a ...

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to ...

Bill Stern, a partner in Goodwin Procter’s financial services practice, said the “pendulum” of regulation is due to swing ...

The Canopy is the latest residential project by EC3, a Detroit office; Prince Concepts, a local developer and landscape firm; ...

The tech-heavy Nasdaq Composite ( ^IXIC) sank nearly 3.5%, while the S&P 500 ( ^GSPC) dropped nearly 2%. The blue-chip Dow ...

(Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial public offering in the United States. The South San Francisco, ...